Centiva Capital’s Xylem XYL Stock Holding History

Centiva Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$148K	–	1638
2025 Q3	$148K	Hold	1,000	–	–	﹤0.01%	878
2025 Q2	$129K	Buy	+1,000	New	+$121K	﹤0.01%	1393

Other funds holding XYL

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Centiva Capital's XYL Position: Q3 2025 in Review

Centiva Capital sold out of Xylem (XYL) in Q3 2025, closing a stake of 9,979 shares — an estimated $1.38M sold.

Centiva Capital first reported a position in XYL in Q2 2021 and held it in 10 quarters. The position peaked at $1.95M in Q2 2024. 1,084 funds tracked by Wall St. Rank hold XYL as of Q3 2025.

Centiva Capital reported no remaining Xylem position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 9,979 Xylem shares in Q3 2025, an estimated $1.38M.
Centiva Capital first reported a position in Xylem in Q2 2021 and held it in 10 quarters.
Centiva Capital's Xylem position peaked at $1.95M in Q2 2024.
1,084 funds tracked by Wall St. Rank held Xylem as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.